• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们如何支持那些停止参与研究的参与者?通过公众与研究者合作制定的沟通指南。

How can we support research participants who stop taking part? Communications guidance developed through public-researcher collaboration.

作者信息

Cragg William J, Bishop Liam, Gilberts Rachael, Gregg Michael, Lowdon Terry, Mancini Mary, Martins de Barros Clara, Wheatstone Pete

机构信息

Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.

Public contributor, Leeds, UK.

出版信息

Res Involv Engagem. 2024 Apr 18;10(1):39. doi: 10.1186/s40900-024-00572-4.

DOI:10.1186/s40900-024-00572-4
PMID:38637845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11025252/
Abstract

BACKGROUND

Research study participants can stop taking part early, in various circumstances. Sometimes this experience can be stressful. Providing participants with the information they want or need when they stop could improve participants' experiences, and may benefit individual studies' objectives and research in general. A group of public contributors and researchers at the Clinical Trials Research Unit, University of Leeds, aimed to develop a communication template and researcher guidance. This would address how to provide information sensitively around the time when participants stop or significantly reduce their level of participation.

METHODS

The project lead used scoping review methods to identify relevant prior evidence and derive a list of potential information topics to communicate to participants who stop taking part. The topic list was reviewed by research professionals and public contributors before finalisation. Further public contributors were identified from a range of networks. The contributors formed a 'development group', to work on the detail of the planned resources, and a larger 'review group' to review the draft output before finalisation. The involvement was planned so that the development group could shape the direction and pace of the work.

RESULTS

The literature review identified 413 relevant reports, resulting in 94 information topics. The review suggested that this issue has not been well explored previously. Some evidence suggested early-stopping participants are sometimes excluded from important communications (such as study results) without clear justification. The development group agreed early to focus on guidance with reusable examples rather than a template. We took time to explore different perspectives and made decisions by informal consensus. Review group feedback was broadly positive but highlighted the need to improve resource navigability, leading to its final online form.

CONCLUSIONS

We co-developed a resource to provide support to research participants who stop taking part. A strength of this work is that several of the public contributors have direct lived experience of stopping research participation. We encourage others to review the resource and consider how they support these participants in their studies. Our work highlights the value of researchers and participants working together, including on complex and ethically challenging topics.

摘要

背景

在各种情况下,研究参与者可以提前退出研究。有时这种经历可能会带来压力。在参与者退出时提供他们想要或需要的信息,可能会改善参与者的体验,并可能有利于个别研究的目标以及整个研究工作。利兹大学临床试验研究单位的一群公众贡献者和研究人员旨在制定一个沟通模板和研究人员指南。这将解决如何在参与者停止或大幅减少参与程度时,敏感地提供信息的问题。

方法

项目负责人采用范围审查方法来识别相关的先前证据,并得出一份潜在信息主题清单,以便传达给停止参与的参与者。在最终确定之前,该主题清单由研究专业人员和公众贡献者进行了审查。从一系列网络中确定了更多的公众贡献者。这些贡献者组成了一个“开发小组”,负责处理计划资源的细节,以及一个更大的“审查小组”,在最终确定之前审查草案输出。计划中的参与方式是,开发小组可以塑造工作的方向和节奏。

结果

文献综述确定了413份相关报告,产生了94个信息主题。该综述表明,此前对这个问题的探讨并不充分。一些证据表明,提前退出的参与者有时会在没有明确理由的情况下被排除在重要沟通(如研究结果)之外。开发小组很早就同意专注于带有可重复使用示例的指南,而不是模板。我们花时间探索不同的观点,并通过非正式协商一致做出决定。审查小组的反馈总体上是积极的,但强调需要提高资源的可导航性,从而形成了最终的在线形式。

结论

我们共同开发了一种资源,为停止参与的研究参与者提供支持。这项工作的一个优点是,一些公众贡献者有直接的停止参与研究的亲身经历。我们鼓励其他人审查该资源,并考虑他们如何在研究中支持这些参与者。我们的工作凸显了研究人员和参与者共同合作的价值,包括在复杂且具有伦理挑战性的主题上的合作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/11025252/ef3aaa780bda/40900_2024_572_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/11025252/1e2654f55ef0/40900_2024_572_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/11025252/828684938c9e/40900_2024_572_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/11025252/42776a1610da/40900_2024_572_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/11025252/ef3aaa780bda/40900_2024_572_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/11025252/1e2654f55ef0/40900_2024_572_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/11025252/828684938c9e/40900_2024_572_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/11025252/42776a1610da/40900_2024_572_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/11025252/ef3aaa780bda/40900_2024_572_Fig4_HTML.jpg

相似文献

1
How can we support research participants who stop taking part? Communications guidance developed through public-researcher collaboration.我们如何支持那些停止参与研究的参与者?通过公众与研究者合作制定的沟通指南。
Res Involv Engagem. 2024 Apr 18;10(1):39. doi: 10.1186/s40900-024-00572-4.
2
Views of research ethics committee members on end-of-participation communications for trial participants who stop taking part: a cross-sectional survey study.研究伦理委员会成员对停止参与试验的参与者的参与结束沟通的看法:一项横断面调查研究。
Trials. 2024 Sep 30;25(1):636. doi: 10.1186/s13063-024-08465-3.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Involving carer advisors in evidence synthesis to improve carers' mental health during end-of-life home care: co-production during COVID-19 remote working.让护理顾问参与证据综合工作以改善临终居家护理期间护理人员的心理健康:新冠疫情远程工作期间的共同制作。
Health Soc Care Deliv Res. 2023 Oct;13(8):1-48. doi: 10.3310/TGHH6428.
5
Time to STEP UP: methods and findings from the development of guidance to help researchers design inclusive clinical trials.加快步伐:制定指导方针以帮助研究人员设计包容性临床试验的方法和研究结果。
BMC Med Res Methodol. 2024 Oct 2;24(1):227. doi: 10.1186/s12874-024-02342-y.
6
Community engagement and involvement in Ghana: conversations with community stakeholders to inform surgical research.加纳的社区参与:与社区利益相关者的对话,为外科研究提供信息。
Res Involv Engagem. 2021 Jul 5;7(1):50. doi: 10.1186/s40900-021-00270-5.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Regional working in the East of England: using the UK National Standards for Public Involvement.英格兰东部的区域工作:采用英国公众参与国家标准。
Res Involv Engagem. 2018 Dec 6;4:48. doi: 10.1186/s40900-018-0130-2. eCollection 2018.
9
Learning to work together - lessons from a reflective analysis of a research project on public involvement.学会协同合作——一项关于公众参与的研究项目反思性分析的经验教训
Res Involv Engagem. 2017 Jan 9;3:1. doi: 10.1186/s40900-016-0051-x. eCollection 2017.
10
"I Knew She'd Get It, and Get Me": Participants' Perspectives of a Participatory Autism Research Project.“我就知道她会成功,也会帮到我”:参与者对一个参与式自闭症研究项目的看法
Autism Adulthood. 2022 Jun 1;4(2):120-129. doi: 10.1089/aut.2021.0039. Epub 2022 Jun 9.

引用本文的文献

1
Views of research ethics committee members on end-of-participation communications for trial participants who stop taking part: a cross-sectional survey study.研究伦理委员会成员对停止参与试验的参与者的参与结束沟通的看法:一项横断面调查研究。
Trials. 2024 Sep 30;25(1):636. doi: 10.1186/s13063-024-08465-3.

本文引用的文献

1
Patient-centred clinical trial design.以患者为中心的临床试验设计。
Nat Rev Nephrol. 2022 Aug;18(8):514-523. doi: 10.1038/s41581-022-00585-w. Epub 2022 Jun 6.
2
Experiences of Patients After Withdrawal From Cancer Clinical Trials.癌症临床试验停药后的患者体验。
JAMA Netw Open. 2021 Aug 2;4(8):e2120052. doi: 10.1001/jamanetworkopen.2021.20052.
3
Feasibility of reporting results of large randomised controlled trials to participants: experience from the Fluoxetine Or Control Under Supervision (FOCUS) trial.向参与者报告大型随机对照试验结果的可行性:来自氟西汀或监督下对照(FOCUS)试验的经验。
BMJ Open. 2020 Nov 30;10(11):e040492. doi: 10.1136/bmjopen-2020-040492.
4
An embedded mixed-methods study highlighted a lack of discussions on retention in clinical trial consultations.一项嵌入式混合方法研究强调了在临床试验咨询中缺乏关于保留问题的讨论。
J Clin Epidemiol. 2020 Jul;123:49-58. doi: 10.1016/j.jclinepi.2020.03.011. Epub 2020 Mar 27.
5
Exploring non-retention in clinical trials: a meta-ethnographic synthesis of studies reporting participant reasons for drop out.探索临床试验中的失访问题:一项综合报告参与者退出原因的元人种学研究。
BMJ Open. 2019 Jun 3;9(6):e021959. doi: 10.1136/bmjopen-2018-021959.
6
Reducing attrition within clinical trials: The communication of retention and withdrawal within patient information leaflets.减少临床试验中的脱落率:在患者知情同意书中沟通保留和退出情况。
PLoS One. 2018 Oct 31;13(10):e0204886. doi: 10.1371/journal.pone.0204886. eCollection 2018.
7
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.PRISMA 扩展用于范围审查 (PRISMA-ScR): 清单和解释。
Ann Intern Med. 2018 Oct 2;169(7):467-473. doi: 10.7326/M18-0850. Epub 2018 Sep 4.
8
Qualitative study of barriers to clinical trial retention in adults with recently diagnosed type 1 diabetes.对近期诊断为1型糖尿病的成年人临床试验保留障碍的定性研究。
BMJ Open. 2018 Jul 17;8(7):e022353. doi: 10.1136/bmjopen-2018-022353.
9
Can user testing of a clinical trial patient information sheet make it fit-for-purpose?--a randomized controlled trial.临床试验患者知情同意书的用户测试能否使其适用?——一项随机对照试验。
BMC Med. 2011 Jul 21;9:89. doi: 10.1186/1741-7015-9-89.
10
Response and non-response to postal questionnaire follow-up in a clinical trial--a qualitative study of the patient's perspective.临床试验中对邮寄问卷调查随访的应答与无应答——基于患者视角的定性研究
J Eval Clin Pract. 2008 Apr;14(2):226-35. doi: 10.1111/j.1365-2753.2007.00838.x. Epub 2007 Dec 13.